$77.17
-0.2-0.26%
At Close: -
$77.55
0.380.49%
After Hours: 3:35 PM EDT
15 minutes delayed
Medtronic
MDTNYSE
Medtronic (NYSE:MDT) Stock, Analyst Ratings, Price Targets, Predictions
Medtronic PLC has a consensus price target of $94.79, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, Goldman Sachs, and RBC Capital on June 5, 2024, May 30, 2024, and May 24, 2024. With an average price target of $89 between RBC Capital, Goldman Sachs, and RBC Capital, there's an implied 14.76% upside for Medtronic PLC from these 3 analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
Goldman Sachs
Wells Fargo
UBS
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Medtronic
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/05/2024 | Buy Now | 18.63% | RBC Capital | Shagun Singh | $92 → $92 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/30/2024 | Buy Now | 7.03% | Goldman Sachs | David Roman | → $83 | Initiates | → Sell | Get Alert |
| 05/24/2024 | Buy Now | 18.63% | RBC Capital | Shagun Singh | → $92 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/24/2024 | Buy Now | 35.4% | Wells Fargo | Larry Biegelsen | $102 → $105 | Maintains | Overweight | Get Alert |
| 05/24/2024 | Buy Now | -2% | UBS | Matthew Taylor | $75 → $76 | Maintains | Sell | Get Alert |
| 05/24/2024 | Buy Now | 13.48% | Truist Securities | Richard Newitter | $90 → $88 | Maintains | Hold | Get Alert |
| 05/24/2024 | Buy Now | — | Needham | Mike Matson | — | Reiterates | → Hold | Get Alert |
| 02/21/2024 | Buy Now | 18.63% | RBC Capital | Shagun Singh | → $92 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 02/21/2024 | Buy Now | 18.63% | Oppenheimer | Steven Lichtman | $89 → $92 | Maintains | Perform | Get Alert |
| 02/21/2024 | Buy Now | 26.37% | Mizuho | Anthony Petrone | $95 → $98 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | 16.05% | Truist Securities | Richard Newitter | $87 → $90 | Maintains | Hold | Get Alert |
| 01/12/2024 | Buy Now | 18.63% | RBC Capital | Shagun Singh | $82 → $92 | Maintains | Sector Perform | Get Alert |
| 12/22/2023 | Buy Now | 12.19% | Truist Securities | Richard Newitter | $84 → $87 | Maintains | Hold | Get Alert |
| 11/22/2023 | Buy Now | 5.74% | RBC Capital | Shagun Singh | → $82 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 11/22/2023 | Buy Now | 26.37% | Morgan Stanley | Cecilia Furlong | $104 → $98 | Maintains | Overweight | Get Alert |
| 08/23/2023 | Buy Now | 14.76% | RBC Capital | Shagun Singh | → $89 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 08/23/2023 | Buy Now | 14.76% | Oppenheimer | Steven Lichtman | → $89 | Reiterates | Perform → Perform | Get Alert |
| 08/23/2023 | Buy Now | 5.74% | UBS | Matthew Taylor | $79 → $82 | Maintains | Sell | Get Alert |
| 08/23/2023 | Buy Now | 28.95% | Mizuho | Anthony Petrone | $95 → $100 | Maintains | Buy | Get Alert |
| 08/23/2023 | Buy Now | 31.53% | Wells Fargo | Larry Biegelsen | $100 → $102 | Maintains | Overweight | Get Alert |
| 08/23/2023 | Buy Now | 22.5% | Stifel | Rick Wise | $92 → $95 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 16.05% | Baird | David Rescott | → $90 | Initiates | → Neutral | Get Alert |
| 06/30/2023 | Buy Now | 36.69% | CL King | Kristen Stewart | → $106 | Initiates | → Buy | Get Alert |
| 05/26/2023 | Buy Now | 14.76% | RBC Capital | Shagun Singh | → $89 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 05/26/2023 | Buy Now | 16.05% | Truist Securities | Richard Newitter | $93 → $90 | Maintains | Hold | Get Alert |
| 05/26/2023 | Buy Now | 18.63% | Stifel | Rick Wise | $90 → $92 | Maintains | Buy | Get Alert |
| 05/26/2023 | Buy Now | 27.66% | Bernstein | Lee Hambright | $100 → $99 | Maintains | Outperform | Get Alert |
| 05/25/2023 | Buy Now | 28.95% | Evercore ISI Group | Vijay Kumar | $88 → $100 | Maintains | Outperform | Get Alert |
| 04/24/2023 | Buy Now | 19.92% | Truist Securities | Richard Newitter | $88 → $93 | Maintains | Hold | Get Alert |
| 04/24/2023 | Buy Now | 34.11% | Barclays | Matt Miksic | $89 → $104 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/24/2023 | Buy Now | 28.95% | Wells Fargo | Larry Biegelsen | $77 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/21/2023 | Buy Now | 14.76% | RBC Capital | Shagun Singh | → $89 | Reiterates | → Sector Perform | Get Alert |
| 04/17/2023 | Buy Now | 13.48% | Truist Securities | Richard Newitter | $90 → $88 | Maintains | Hold | Get Alert |
| 01/24/2023 | Buy Now | 22.5% | Mizuho | Anthony Petrone | $100 → $95 | Maintains | Buy | Get Alert |
| 01/09/2023 | Buy Now | 14.76% | RBC Capital | Shagun Singh | $102 → $89 | Downgrade | Outperform → Sector Perform | Get Alert |
| 11/30/2022 | Buy Now | -0.71% | Wells Fargo | Larry Biegelsen | $82 → $77 | Maintains | Equal-Weight | Get Alert |
| 11/25/2022 | Buy Now | 9.61% | Barclays | Matt Miksic | $90 → $85 | Maintains | Equal-Weight | Get Alert |
| 11/23/2022 | Buy Now | 31.53% | RBC Capital | Shagun Singh | $110 → $102 | Maintains | Outperform | Get Alert |
| 11/23/2022 | Buy Now | 9.61% | Oppenheimer | Steven Lichtman | $106 → $85 | Downgrade | Outperform → Perform | Get Alert |
| 11/23/2022 | Buy Now | 13.48% | Morgan Stanley | Cecilia Furlong | $97 → $88 | Maintains | Equal-Weight | Get Alert |
| 11/23/2022 | Buy Now | 9.61% | Citigroup | Joanne Wuensch | $108 → $85 | Downgrade | Buy → Neutral | Get Alert |
| 10/18/2022 | Buy Now | 16.05% | Barclays | Matt Miksic | → $90 | Initiates | → Equal-Weight | Get Alert |
| 10/17/2022 | Buy Now | 14.76% | Truist Securities | Richard Newitter | $97 → $89 | Maintains | Hold | Get Alert |
| 10/13/2022 | Buy Now | 28.95% | Mizuho | Anthony Petrone | → $100 | Initiates | → Buy | Get Alert |
| 10/12/2022 | Buy Now | 12.19% | Jefferies | Matthew Taylor | → $87 | Initiates | → Hold | Get Alert |
| 10/11/2022 | Buy Now | 25.08% | Morgan Stanley | Cecilia Furlong | $101 → $97 | Maintains | Equal-Weight | Get Alert |
| 09/07/2022 | Buy Now | 41.84% | RBC Capital | Shagun Singh | $122 → $110 | Maintains | Outperform | Get Alert |
| 08/24/2022 | Buy Now | 30.24% | Morgan Stanley | Cecilia Furlong | $103 → $101 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | Buy Now | 23.79% | Wells Fargo | Larry Biegelsen | $104 → $96 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | Buy Now | — | Raymond James | Jayson Bedford | — | Downgrade | Outperform → Market Perform | Get Alert |
| 07/20/2022 | Buy Now | 25.08% | Truist Securities | Richard Newitter | $111 → $97 | Maintains | Hold | Get Alert |
| 07/18/2022 | Buy Now | 35.4% | Stifel | Rick Wise | $125 → $105 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 32.82% | Morgan Stanley | Cecilia Furlong | $114 → $103 | Maintains | Equal-Weight | Get Alert |
| 07/06/2022 | Buy Now | — | Wolfe Research | Mike Polark | — | Initiates | → Underperform | Get Alert |
| 06/07/2022 | Buy Now | 47% | Morgan Stanley | Cecilia Furlong | $115 → $114 | Maintains | Equal-Weight | Get Alert |
| 06/01/2022 | Buy Now | 35.4% | Atlantic Equities | James Mainwaring | $125 → $105 | Downgrade | Overweight → Neutral | Get Alert |
| 05/31/2022 | Buy Now | 43.13% | Truist Securities | Richard Newitter | $121 → $111 | Maintains | Hold | Get Alert |
| 05/31/2022 | Buy Now | 40.55% | Raymond James | Jayson Bedford | $116 → $109 | Maintains | Outperform | Get Alert |
| 05/27/2022 | Buy Now | 50.87% | Cowen & Co. | Joshua Jennings | $125 → $117 | Maintains | Outperform | Get Alert |
| 05/27/2022 | Buy Now | 57.32% | RBC Capital | Shagun Singh | $135 → $122 | Maintains | Outperform | Get Alert |
| 05/27/2022 | Buy Now | 56.03% | Deutsche Bank | Pito Chickering | $149 → $121 | Maintains | Buy | Get Alert |
| 05/27/2022 | Buy Now | 48.29% | Morgan Stanley | Cecilia Furlong | $120 → $115 | Maintains | Equal-Weight | Get Alert |
| 05/27/2022 | Buy Now | 50.87% | Citigroup | Joanne Wuensch | $120 → $117 | Maintains | Buy | Get Alert |
| 05/27/2022 | Buy Now | 28.95% | Piper Sandler | Matt O'Brien | $105 → $100 | Maintains | Neutral | Get Alert |
| 05/27/2022 | Buy Now | — | Needham | Mike Matson | — | Downgrade | Buy → Hold | Get Alert |
| 05/23/2022 | Buy Now | 61.19% | Cowen & Co. | Joshua Jennings | $141 → $125 | Maintains | Outperform | Get Alert |
| 05/17/2022 | Buy Now | 54.74% | Citigroup | Joanne Wuensch | $127 → $120 | Maintains | Buy | Get Alert |
| 02/23/2022 | Buy Now | 74.08% | Credit Suisse | Matt Miksic | $142 → $135 | Maintains | Outperform | Get Alert |
| 02/23/2022 | Buy Now | 59.9% | Needham | Mike Matson | $128 → $124 | Maintains | Buy | Get Alert |
| 02/18/2022 | Buy Now | 49.58% | Raymond James | Jayson Bedford | $127 → $116 | Maintains | Outperform | Get Alert |
| 02/16/2022 | Buy Now | 35.4% | Piper Sandler | Matt O'Brien | $110 → $105 | Maintains | Neutral | Get Alert |
| 01/25/2022 | Buy Now | 65.06% | Needham | Mike Matson | $131 → $128 | Maintains | Buy | Get Alert |
| 01/21/2022 | Buy Now | 48.29% | SVB Leerink | Danielle Antalffy | $138 → $115 | Maintains | Market Perform | Get Alert |
| 01/19/2022 | Buy Now | 66.34% | Citigroup | Joanne Wuensch | $130 → $129 | Maintains | Buy | Get Alert |
| 01/18/2022 | Buy Now | 48.29% | Goldman Sachs | Amit Hazan | $129 → $115 | Maintains | Neutral | Get Alert |
| 01/10/2022 | Buy Now | — | BTIG | Sean Lavin | — | Downgrade | Buy → Neutral | Get Alert |
| 01/07/2022 | Buy Now | 54.74% | Morgan Stanley | Cecilia Furlong | $145 → $120 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/04/2022 | Buy Now | 41.84% | Piper Sandler | Matt O'Brien | $152 → $110 | Downgrade | Overweight → Neutral | Get Alert |
| 12/21/2021 | Buy Now | 59.9% | Truist Securities | Kaila Krum | $142 → $124 | Maintains | Buy | Get Alert |
| 12/20/2021 | Buy Now | 83.11% | Credit Suisse | Matt Miksic | — | Maintains | Outperform | Get Alert |
| 12/17/2021 | Buy Now | 75.37% | Oppenheimer | Steven Lichtman | — | Maintains | Outperform | Get Alert |
| 12/17/2021 | Buy Now | 65.06% | BTIG | Ryan Zimmerman | — | Maintains | Buy | Get Alert |
| 12/17/2021 | Buy Now | 35.4% | JP Morgan | Robbie Marcus | — | Downgrade | Overweight → Neutral | Get Alert |
| 12/16/2021 | Buy Now | 41.84% | Wells Fargo | Larry Biegelsen | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/16/2021 | Buy Now | 68.92% | Needham | Mike Matson | — | Maintains | Buy | Get Alert |
| 12/10/2021 | Buy Now | 80.53% | RBC Capital | Shagun Singh | — | Initiates | → Outperform | Get Alert |
| 11/24/2021 | Buy Now | 88.27% | Citigroup | — | — | Maintains | Buy | Get Alert |
| 11/24/2021 | Buy Now | 86.98% | Morgan Stanley | Cecilia Furlong | — | Maintains | Overweight | Get Alert |
| 11/24/2021 | Buy Now | 86.98% | Oppenheimer | Steven Lichtman | — | Maintains | Outperform | Get Alert |
| 11/24/2021 | Buy Now | 76.66% | Wells Fargo | Larry Biegelsen | — | Maintains | Overweight | Get Alert |
| 11/23/2021 | Buy Now | 86.98% | Needham | Mike Matson | — | Maintains | Buy | Get Alert |
| 10/18/2021 | Buy Now | 85.69% | Wells Fargo | Larry Biegelsen | — | Maintains | Overweight | Get Alert |
| 08/27/2021 | Buy Now | 112.77% | Argus Research | David Toung | — | Maintains | Buy | Get Alert |
| 08/25/2021 | Buy Now | 90.84% | Truist Securities | Kaila Krum | — | Maintains | Buy | Get Alert |
| 08/25/2021 | Buy Now | 97.29% | Citigroup | Joanne Wuensch | — | Maintains | Buy | Get Alert |
| 08/25/2021 | Buy Now | 92.13% | UBS | Matthew Taylor | — | Maintains | Buy | Get Alert |
| 08/25/2021 | Buy Now | 86.98% | Stifel | Rick Wise | — | Maintains | Buy | Get Alert |
| 08/25/2021 | Buy Now | 98.58% | Morgan Stanley | David Lewis | — | Maintains | Overweight | Get Alert |
| 08/25/2021 | Buy Now | 83.11% | Raymond James | Jayson Bedford | — | Maintains | Outperform | Get Alert |
| 08/25/2021 | Buy Now | 94.71% | Wells Fargo | Larry Biegelsen | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Medtronic (MDT) stock?
The latest price target for Medtronic (NYSE:MDT) was reported by RBC Capital on June 5, 2024. The analyst firm set a price target for $92.00 expecting MDT to rise to within 12 months (a possible 18.63% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Medtronic (MDT)?
The latest analyst rating for Medtronic (NYSE:MDT) was provided by RBC Capital, and Medtronic reiterated their sector perform rating.
When was the last upgrade for Medtronic (MDT)?
The last upgrade for Medtronic PLC happened on April 24, 2023 when Barclays raised their price target to $104. Barclays previously had an equal-weight for Medtronic PLC.
When was the last downgrade for Medtronic (MDT)?
The last downgrade for Medtronic PLC happened on January 9, 2023 when RBC Capital changed their price target from $102 to $89 for Medtronic PLC.
When is the next analyst rating going to be posted or updated for Medtronic (MDT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medtronic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medtronic was filed on June 5, 2024 so you should expect the next rating to be made available sometime around June 5, 2025.
Is the Analyst Rating Medtronic (MDT) correct?
While ratings are subjective and will change, the latest Medtronic (MDT) rating was a reiterated with a price target of $92.00 to $92.00. The current price Medtronic (MDT) is trading at is $77.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.